BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3306131)

  • 1. [Medulloblastoma therapy studies MBL 80 and MED 84 of the Society of Pediatric Oncology and the Société Internationale d'Oncologie Pédiatrique (SIOP)].
    Neidhardt M; Bailey CC; Gnekow A; Kleihues P; Michaelis J; Wellek S
    Klin Padiatr; 1987; 199(3):188-92. PubMed ID: 3306131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I).
    Tait DM; Thornton-Jones H; Bloom HJ; Lemerle J; Morris-Jones P
    Eur J Cancer; 1990 Apr; 26(4):464-9. PubMed ID: 2141512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Medulloblastomas--the results after postoperative radiotherapy with and without adjuvant chemotherapy].
    Grabenbauer GG; Löhnert C; Erhardt J; Buchfelder M; Neubauer U; Beck JD; Reitz S; Seyer H; Thierauf P; Fietkau R
    Strahlenther Onkol; 1993 Apr; 169(4):213-21. PubMed ID: 8488458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma.
    Chi SN; Gardner SL; Levy AS; Knopp EA; Miller DC; Wisoff JH; Weiner HL; Finlay JL
    J Clin Oncol; 2004 Dec; 22(24):4881-7. PubMed ID: 15611503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Medulloblastoma study of the German Society for Pediatric Oncology, a first report].
    Neidhardt M; Habermalz HJ; Henze G; Langermann HJ
    Klin Padiatr; 1982; 194(4):257-61. PubMed ID: 7132227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose reductions of vincristine in children with medulloblastoma treated in the maintenance arm of the prospective multicenter trial HIT'91.
    von Bueren AO; von Hoff K; Benesch M; Rutkowski S
    Klin Padiatr; 2009; 221(6):396-7. PubMed ID: 19890797
    [No Abstract]   [Full Text] [Related]  

  • 7. Outcome for patients with metastatic (M2-3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy.
    Taylor RE; Bailey CC; Robinson KJ; Weston CL; Walker DA; Ellison D; Ironside J; Pizer BL; Lashford LS
    Eur J Cancer; 2005 Mar; 41(5):727-34. PubMed ID: 15763649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma.
    Massimino M; Gandola L; Spreafico F; Biassoni V; Luksch R; Collini P; Solero CN; Simonetti F; Pignoli E; Cefalo G; Poggi G; Modena P; Mariani L; Potepan P; Podda M; Casanova M; Pecori E; Acerno S; Ferrari A; Terenziani M; Meazza C; Polastri D; Ravagnani F; Fossati-Bellani F
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1358-63. PubMed ID: 19019566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.
    Packer RJ; Gajjar A; Vezina G; Rorke-Adams L; Burger PC; Robertson PL; Bayer L; LaFond D; Donahue BR; Marymont MH; Muraszko K; Langston J; Sposto R
    J Clin Oncol; 2006 Sep; 24(25):4202-8. PubMed ID: 16943538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant chemotherapy with procarbazine, vincristine and prednisone for medulloblastomas. A preliminary report.
    Seiler RW; Bernasconi S; Berchtold W; Feldges A; Imbach P; Lüthi A; Plüss HJ; Vassella F; Wyss M; Wagner HP
    Helv Paediatr Acta; 1981 Jul; 36(3):249-54. PubMed ID: 7275674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the "Head Start" I and II protocols.
    Dhall G; Grodman H; Ji L; Sands S; Gardner S; Dunkel IJ; McCowage GB; Diez B; Allen JC; Gopalan A; Cornelius AS; Termuhlen A; Abromowitch M; Sposto R; Finlay JL
    Pediatr Blood Cancer; 2008 Jun; 50(6):1169-75. PubMed ID: 18293379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective randomized cooperative medulloblastoma trial (MED 84) of the International Society of Paediatric Oncology (SIOP) and of the (German) Society of Paediatric Oncology (GPO).
    Neidhardt MK; Bailey CC
    Childs Nerv Syst; 1987; 3(2):70-3. PubMed ID: 3304625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II.
    Bailey CC; Gnekow A; Wellek S; Jones M; Round C; Brown J; Phillips A; Neidhardt MK
    Med Pediatr Oncol; 1995 Sep; 25(3):166-78. PubMed ID: 7623725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastoma.
    Taylor RE; Bailey CC; Robinson KJ; Weston CL; Ellison D; Ironside J; Lucraft H; Gilbertson R; Tait DM; Saran F; Walker DA; Pizer BL; Lashford LS; ;
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1184-93. PubMed ID: 15001263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival of adults treated for medulloblastoma using paediatric protocols.
    Spreafico F; Massimino M; Gandola L; Cefalo G; Mazza E; Landonio G; Pignoli E; Poggi G; Terenziani M; Pedrazzoli P; Siena S; Fossati-Bellani F
    Eur J Cancer; 2005 Jun; 41(9):1304-10. PubMed ID: 15869875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitrogen mustard, vincristine, procarbazine, and prednisone as adjuvant chemotherapy in the treatment of medulloblastoma. A Pediatric Oncology Group study.
    Krischer JP; Ragab AH; Kun L; Kim TH; Laurent JP; Boyett JM; Cornell CJ; Link M; Luthy AR; Camitta B
    J Neurosurg; 1991 Jun; 74(6):905-9. PubMed ID: 2033450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timing of radiation in children with medulloblastoma/PNET.
    Santos MA; Viégas CM; Servidoni RA; Barros MH; Pinel MI; Araújo CM
    Pediatr Blood Cancer; 2007 Apr; 48(4):416-22. PubMed ID: 17034032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and severity of postoperative cerebellar mutism syndrome in children with medulloblastoma: a prospective study by the Children's Oncology Group.
    Robertson PL; Muraszko KM; Holmes EJ; Sposto R; Packer RJ; Gajjar A; Dias MS; Allen JC;
    J Neurosurg; 2006 Dec; 105(6 Suppl):444-51. PubMed ID: 17184075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The therapy of infantile malignant brain tumors: current status?
    Kalifa C; Grill J
    J Neurooncol; 2005 Dec; 75(3):279-85. PubMed ID: 16195802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of high risk medulloblastomas in children above the age of 3 years: a SFOP study.
    Verlooy J; Mosseri V; Bracard S; Tubiana AL; Kalifa C; Pichon F; Frappaz D; Chastagner P; Pagnier A; Bertozzi AI; Gentet JC; Sariban E; Rialland X; Edan C; Bours D; Zerah M; Le Gales C; Alapetite C; Doz F
    Eur J Cancer; 2006 Nov; 42(17):3004-14. PubMed ID: 16956759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.